bioRxivEvolutionary BiologyPreprint
The N-glycosylation sites and Glycan-binding ability of S-protein in SARS-CoV-2 Coronavirus
Abstract
The emerging acute respiratory disease, COVID-19, caused by SARS-CoV-2 Coronavirus (SARS2 CoV) has spread fastly all over the word. As a member of RNA viruses, the glycosylation of envelope glycoprotein plays the crucial role in protein folding, evasing host immune system, invading host cell membrane, even affecting host preference. Therefore, detail glyco-related researches have been adopted in the Spike protein (S-protein) of SARS2 CoV from the bioinformatic perspective. Phylogenic analysis of S-protein sequences revealed the evolutionary relationship of N-glycosylation sites in different CoVs. Structural comparation of S-proteins indicated their similarity and distributions of N-glycosylation sites. Further potential sialic acid or galactose affinity domains have been described in the S-protein by docking analysis. Molecular dynamic simulation for the glycosylated complexus of S-protein-ACE2 implied that the complicate viral binding of receptor-binding domain may be influenced by peripheric N-glycans from own and adjacent monoers. These works will contribute to investigate the N-glycosylation in S-protein and explain the highly contagious of COVID-19.
- organism: virus
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike
Ahmad Reza Mehdipour, Gerhard Hummer·Proceedings of the National Academy of SciencesPeer-reviewed·May 11, 2021
- Beyond Shielding: The Roles of Glycans in SARS-CoV-2 Spike Protein
L. Casalino, Z. Gaieb, … R. E. Amaro·bioRxiv·Jun 11, 2020
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins
- Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor
P. Zhao, J. L. Praissman, … L. Wells·bioRxiv·Jun 25, 2020
- Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2.
A. Shajahan, S. A. Archer-Hartmann, … P. Azadi·bioRxiv·May 1, 2020
- ACE2 glycans preferentially interact with the RBD of SARS-CoV-2 over SARS-CoV
A. Acharya, D. Lynch, … J. Gumbart·bioRxiv·Apr 29, 2021